Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.
about
The Role of Proteomics in Biomarker Development for Improved Patient Diagnosis and Clinical Decision Making in Prostate CancerQuantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progressionRac1 activation driven by 14-3-3ζ dimerization promotes prostate cancer cell-matrix interactions, motility and transendothelial migrationBioinformatics analysis of differentially expressed proteins in prostate cancer based on proteomics dataConstruction and analysis of protein-protein interaction networks based on proteomics data of prostate cancerProstate cancer proteomics: Current trends and future perspectives for biomarker discovery.Differential marker expression by cultures rich in mesenchymal stem cellsDifferentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancerPossible Involvement of F1F0-ATP synthase and Intracellular ATP in Keratinocyte Differentiation in normal skin and skin lesions.Targeting 14-3-3zeta in cancer therapy.Proteomics in studying cancer stem cell biology.Novel approaches for the identification of biomarkers of aggressive prostate cancerDatabase-augmented Mass Spectrometry Analysis of Exosomes Identifies Claudin 3 as a Putative Prostate Cancer Biomarker.Preapoptotic protease calpain-2 is frequently suppressed in adult T-cell leukemiaImplication of 14-3-3ε and 14-3-3θ/τ in proteasome inhibition-induced apoptosis of glioma cells.Inhibitory effect of rape pollen supercritical CO2 fluid extract against testosterone-induced benign prostatic hyperplasia in rats.Proteomics analysis of urine reveals acute phase response proteins as candidate diagnostic biomarkers for prostate cancer.Proteomics analysis of malignant and benign prostate tissue by 2D DIGE/MS reveals new insights into proteins involved in prostate cancer.Prostate cancer in the Arab population. An overview
P2860
Q26738703-BE84D18B-0AC0-4587-80B1-83891239353BQ28286300-D437F164-EC07-4321-B55C-5E28DDA721B2Q28481314-B44B1D33-585B-4C5E-9332-CFB5D9184CADQ31070165-38BF892F-C37A-4099-82D4-E75FA4657F8AQ31086270-3061FAC3-3296-436F-A812-66D2886BBF5BQ33567004-284CBD09-46FD-4FA0-A1F1-8A23BDD576D6Q34530562-8F05223D-EFB6-4CC5-908C-072D0030E20DQ35873154-6231CC59-A6FF-4EAB-BB70-07A599D6C2E7Q36298306-E3B21CA7-5D34-4D3F-80CA-40A67634AA8BQ37648550-3F7FEF5F-E6C3-44B7-98B6-372B245FFAF1Q37970918-875836E5-6513-447F-B21A-E14E4C68BB0CQ38027219-8A3CDF89-E4C4-4A33-A141-8AE9979A520FQ38117841-099D81A6-AC5A-4932-9655-27C5861784B7Q38378261-E36AE497-CEB9-4FD4-98B2-0E1B95EDFA23Q39095736-22303F49-F522-41E9-BB73-E20C36BE9C22Q39269737-3C493007-E2E8-4052-833B-B63B9D419EDBQ40818269-7D852851-753C-424C-86C7-C4077849D358Q42067159-76B5B710-9EC1-46A2-AA1D-8D56C99AAA06Q52936872-1C39C622-2D8A-4596-A784-93FDC588FB9AQ57113351-EAFB23BA-E744-455C-8052-54D6CBA09578
P2860
Proteomics-based signature for human benign prostate hyperplasia and prostate adenocarcinoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@en
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@nl
type
label
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@en
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@nl
prefLabel
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@en
Proteomics-based signature for ...... a and prostate adenocarcinoma.
@nl
P2093
P356
P1476
Proteomics-based signature for ...... ia and prostate adenocarcinoma
@en
P2093
Ali Bin Mahfooz
Asma Tulbah
Ayodele A Alaiya
Chaker Adra
Irfan Ahmad
Kamal Hanash
Layla Al-Mansouri
Maha Al-Rodayan
Mai Al-Mohanna
Muhammad Aslam
P304
P356
10.3892/IJO.2011.937
P50
P577
2011-02-08T00:00:00Z